Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Elyse P Lemke x
  • Refine by access: Content accessible to me x
Clear All Modify Search
Elyse P Lemke
Search for other papers by Elyse P Lemke in
Google Scholar
PubMed
Close
,
Betty M Adams
Search for other papers by Betty M Adams in
Google Scholar
PubMed
Close
,
Albina Jablonka-Shariff Department of Animal Science, Department of Molecular Biology and Pharmacology, University of California, Davis, California 95616, USA

Search for other papers by Albina Jablonka-Shariff in
Google Scholar
PubMed
Close
,
Irving Boime Department of Animal Science, Department of Molecular Biology and Pharmacology, University of California, Davis, California 95616, USA

Search for other papers by Irving Boime in
Google Scholar
PubMed
Close
, and
Thomas E Adams
Search for other papers by Thomas E Adams in
Google Scholar
PubMed
Close

The biopotency of single-chain analogs of human hFSH, human chorionic gonadotropin (hCG), and a dually active gonadotropin construct (FcCGβα) was examined. Sheep (bwt=61.4±1.1 kg; n=6 ewes/treatment) received a single injection (5 IU/kg, i.v.) of the hFSH analog (Fcα), the hCG analog (CGβα), FcCGβα, or Fcα and CGβα. Control animals received conditioned media. Ovulation was induced 3 days after analog administration using hCG (1000 IU, i.v.). Basal serum concentrations of estradiol (E2) were maintained in control animals. Neither Fcα nor CGβα alone induced significant E2 production during the pre-hCG period. Conversely, serum concentrations of E2 were increased (P<0.05) 2 days after administration of FcCGβα or Fcα+ CGβα. Although P4 concentrations were maintained at basal levels in control animals, significant increase was noted in all other treatment groups during the post-hCG period. Final ovarian weight was significantly increased (P<0.05) in animals receiving Fcα, Fcα+ CGβα, or FcCGβα, but not CGβα alone. Most of the ovarian enlargement was attributed to the formation of corpora lutea. Collectively, these observations demonstrate that the single-chain analogs of the human gonadotropins are active in sheep. The construct with singular FSH activity supports follicle development but not E2 production. Conversely, the construct that incorporates β-domains from both CG and FSH has dual activity. The long-lived nature of the single-chain constructs suggests that these recombinant gonadotropins may be effective alternatives to pituitary- or placenta-derived gonadotropins in out-of-season breeding and/or superovulation protocols.

Free access